首页|梗阻性肾病患者的肾脏纤维化与血清EZH2表达的关系

梗阻性肾病患者的肾脏纤维化与血清EZH2表达的关系

扫码查看
目的 探讨Zeste基因增强子同源物2(EZH2)的表达变化与梗阻性肾病患者的肾脏纤维化的关系.方法 回顾性研究2020年1月至2021年5月在廊坊市人民医院收治的95例梗阻性肾病患者的临床资料(梗阻性肾病组),记录患者的估算肾小球滤过率(eGFR)、24 h尿蛋白等资料,根据肾组织纤维化程度将患者分为0级组(26例)、Ⅰ级组(47例)和Ⅱ级组(22例).同期收集94例体检健康人群作为对照组.采用实时荧光定量PCR(qRT-PCR)法检测血清EZH2 mRNA的相对表达量;采用受试者工作特征(ROC)曲线分析血清EZH2 mRNA水平对梗阻性肾病患者肾脏纤维化的评估价值;采用logistic回归分析梗阻性肾病患者肾脏纤维化程度的影响因素.结果 梗阻性肾病组的血清EZH2 mRNA水平高于对照组(t=29.761,P<0.05).梗阻性肾病组患者的血清EZH2 mRNA水平与性别、年龄、体质量指数(BMI)均无相关性(均P>0.05),而与估算肾小球滤过率(eGFR)、24 h尿蛋白、间质炎症评分均有相关性(均P<0.05).eGFR<60 mL·(min·1.73 m2)-1、24 h 尿蛋白 ≥3.5 g/24 h、间质炎症评分为 1、2分的梗阻性肾病患者的血清EZH2 mRNA水平均高于eGFR≥60 mL·(min·1.73 m2)-1、24 h尿蛋白<3.5 g/24 h、间质炎症评分为0分的患者(均P<0.05).随着肾脏纤维化程度的升高,梗阻性肾病患者的血清EZH2 mRNA水平升高(F=26.473,P<0.05).血清EZH2 mRNA水平评估梗阻性肾病患者Ⅰ级组患者肾脏纤维化的曲线下面积(AUC)为0.724(95%CI:0.603~0.845),特异度为69.2%,灵敏度为76.6%,截断值为2.42;评估Ⅱ级组患者肾脏纤维化的AUC为 0.853(95%CI:0.766~0.940),特异度为 68.1%,灵敏度为 95.5%,截断值为 2.90.EZH2 mRNA是梗阻性肾病患者肾脏纤维化程度发展为I级或Ⅱ级的影响因素(均P<0.05).结论 血清EZH2与梗阻性肾病患者的肾脏纤维化程度呈正相关,可有效评估肾脏纤维化程度.
The relationship between renal fibrosis in patients with obstructive nephropathy and serum EZH2 expression
Objective To explore the relationship between the expression changes of enhancer of Zeste homolog 2(EZH2)and renal fibrosis in patients with obstructive nephropathy.Methods The clinical data of 95 patients with obstructive nephropathy admitted to Langfang People's Hospital from Jan-uary 2020 to May 2021(obstructive nephropathy group)were retrospectively studied,and the estimated glomerular filtration rate(eGFR)and 24-hour urinary protein of patients were recorded.According to the degree of renal fibrosis,the patients were divided into grade 0 group(26 cases),grade Ⅰ group(47 cases)and grade Ⅱ group(22 cases).In the same period,94 healthy subjects were collected as control group.The relative expression of EZH2 mRNA in the above serum was detected by real-time quantitative PCR(qRT-PCR)method;receiver operating characteristic(ROC)curve was used to an-alyze the value of serum EZH2 mRNA level in evaluating renal tissue fibrosis in patients with obstruc-tive nephropathy,and logistic regression was used to analyze the influencing factors of renal tissue fibro-sis in patients with obstructive nephropathy.Results The serum EZH2 mRNA level in the obstructive nephropathy group was higher than that in the control group,and the difference was statistically signifi-cant(t=29.761,P<0.05).The serum EZH2 mRNA levels in patients with obstructive kidney dis-ease were not correlated with gender,age,and BMI(all P>0.05),but were correlated with eGFR,24-hour urine protein,and interstitial inflammation(all P<0.05).The serum EZH2 mRNA levels in patients with obstructive nephropathy with eGFR<60 mL·(min·1.73 m2)-1 were higher than those in patients with eGFR ≥60 mL·(min·1.73 m2)-1.The serum EZH2 mRNA levels in pa-tients with obstructive nephropathy with 24-hour urine protein ≥3.5 g/24 h were higher than those in patients with 24-hour urine protein<3.5 g/24 h.The serum EZH2 mRNA levels in patients with ob-structive nephropathy with interstitial inflammation scores of 1 and 2 were higher than those in patients with interstitial inflammation scores of 0,the differences were statistically significant(all P<0.05).As the degree of renal fibrosis increases,the serum EZH2 mRNA levels in patients with obstructive kidney disease increase sequentially(F=26.473,P<0.05).The area under the curve(AUC)of se-rum EZH2 mRNA levels for evaluating renal fibrosis in patients with obstructive kidney disease gradeⅠ group was 0.724(95%CI:0.603-0.845),with a specificity of 69.2%,sensitivity of 76.6%,and cutoff value of 2.42.The AUC of renal fibrosis in grade Ⅱ group was 0.853(95%CI:0.766-0.940),with a specifiicity of 68.1%,sensitivity of 95.5%,and cutoff value of 2.90.EZH2 mRNA was an influence factor for the development of grade Ⅰ and grade Ⅱ renal fibrosis in patients with ob-structive nephropathy(all P<0.05).Conclusions Serum EZH2 mRNA is positively correlated with the degree of renal tissue fibrosis in patients with obstructive nephropathy,which can effectively evalu-ate the degree of renal tissue fibrosis.

Enhancer of Zeste Homolog 2 ProteinFibrosisKidneyObstructive Nephropathy

刘亮、刘杨、王景超、张瑜

展开 >

廊坊市人民医院泌尿外科,廊坊 065099

廊坊市人民医院麻醉科,廊坊 065099

保定市第二中心医院泌尿外科,保定 072750

Zeste同源蛋白2增强子 纤维化 梗阻性肾病

保定市科技计划

2141ZF030

2024

国际泌尿系统杂志
中华医学会,湖南省医学会

国际泌尿系统杂志

CSTPCD
影响因子:0.414
ISSN:1673-4416
年,卷(期):2024.44(3)
  • 17